Skip to main content
Signal8

Carr Douglas

SEC insider (Form 3/4/5 filer). CIK 0001867173. SVP Finance & Operations at Century Therapeutics, Inc. (IPSC). 21 reported Form 4/5 transactions since Sep 2024; latest on Sep 14, 2026. Located in PHILADELPHIA, PA.

Companies Carr Douglas has filed insider reports for

  • Century Therapeutics, Inc. (IPSC): Officer, SVP Finance & Operations
Carr Douglas profile photo

Carr Douglas

CIK: 0001867173

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)18 (85.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (9.5%)

Compensation grants

Other (G, F, J, C, D, …)1 (4.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Century Therapeutics, Inc. logo
IPSC

Century Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (21 total)

  • Century Therapeutics, Inc. logo
    IPSC

    Century Therapeutics, Inc.

    Sep 14, 2026
    Sale
    Direct
    1.7K shares at avg. $1.93$3K
  • Century Therapeutics, Inc. logo
    IPSC

    Century Therapeutics, Inc.

    Sep 8, 2026
    Sale
    Direct
    254 shares at avg. $2.05$520.7
  • Century Therapeutics, Inc. logo
    IPSC

    Century Therapeutics, Inc.

    Aug 3, 2026
    Sale
    Direct
    275 shares at avg. $1.98$543.675
  • Century Therapeutics, Inc. logo
    IPSC

    Century Therapeutics, Inc.

    Jun 12, 2026
    Sale
    Direct
    1.7K shares at avg. $2.23$4K
  • Century Therapeutics, Inc. logo
    IPSC

    Century Therapeutics, Inc.

    Jun 8, 2026
    Sale
    Direct
    249 shares at avg. $2.11$525.639
  • Century Therapeutics, Inc. logo
    IPSC

    Century Therapeutics, Inc.

    May 4, 2026
    Sale
    Direct
    264 shares at avg. $2.34$618.024
  • Century Therapeutics, Inc. logo
    IPSC

    Century Therapeutics, Inc.

    Mar 12, 2026
    Sale
    Direct
    7K shares at avg. $2.55$18K
  • Century Therapeutics, Inc. logo
    IPSC

    Century Therapeutics, Inc.

    Mar 9, 2026
    Sale
    Direct
    247 shares at avg. $2.54$626.392
  • Century Therapeutics, Inc. logo
    IPSC

    Century Therapeutics, Inc.

    Feb 3, 2026
    Sale
    Direct
    323 shares at avg. $1.82$588.506
  • Century Therapeutics, Inc. logo
    IPSC

    Century Therapeutics, Inc.

    Feb 2, 2026
    Award
    Direct
    110K shares-

1-10 of 21